EA
GHDX

Emerald Acquisition’s Genomic Health, Inc. GHDX Stock Holding History

Emerald Acquisition’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$1.15M Sell
39,783
-36,782
-48% -$1.02M ﹤0.01% 2053
2016
Q2 		$1.98M Buy
+76,565
New +$2.03M ﹤0.01% 1831

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Emerald Acquisition's GHDX Position: Q3 2016 in Review

Emerald Acquisition reduced its Genomic Health, Inc. (GHDX) stake by 48% in Q3 2016, selling an estimated $1.02M and leaving 39,783 shares worth $1.15M. The position accounts for ﹤0.01% of the portfolio, ranked #2053.

Emerald Acquisition first reported a position in GHDX in Q2 2016 and has held it in 2 quarters since. The position peaked at $1.98M in Q2 2016. 134 funds tracked by Wall St. Rank hold GHDX as of Q3 2016.

  • Emerald Acquisition held 39,783 shares of Genomic Health, Inc. worth $1.15M as of Q3 2016.
  • Emerald Acquisition sold 36,782 Genomic Health, Inc. shares in Q3 2016, an estimated $1.02M.
  • Genomic Health, Inc. made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #2053 holding.
  • Emerald Acquisition first reported a position in Genomic Health, Inc. in Q2 2016 and has held it in 2 quarters since.
  • Emerald Acquisition's Genomic Health, Inc. position peaked at $1.98M in Q2 2016.
  • 134 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.